Business
ZEN Graphene Solutions Comments on Graphene in Protective Face Masks
GUELPH, ON / ACCESSWIRE / April 5, 2021 / ZEN Graphene Solutions Ltd. (" ZEN " or the " Co...
About this update from Zentek Ltd.
[{"type":"text","content":"ZEN Graphene Solutions Comments on Graphene in Protective Face MasksGUELPH, ON / ACCESSWIRE / April 5, 2021 / ZEN Graphene Solutions Ltd. (\"ZEN\" or the \"Company\") (TSXV:ZEN) and (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is aware of the statements from Health Canada (HC) regarding masks containing graphene and is aligned and supportive of the steps taken to regulate the use of graphene and remove products that are unsafe for the public. ZEN has had comprehensive testing performed on its biocidal coating and demonstrated that it can provide an added level of protection for front-line workers and the public. Most importantly, Nucro-Technics (a world-renowned testing facility) has performed extensive testing for cytotoxicity, irritation and skin sensitization and shown that its product is safe. Our partner Trebor Rx Corp. (Trebor) has also completed considerable testing on masks and has successfully passed Canadian requirements as a level 1 Medical Device for ASTM Level 1,2 and very recently, level 3, the highest level for surgical masks.Beyond safety testing on masks, ZEN is actively exploring using its formulation for potential human use as a pharmaceutical product and has completed two phases of safety testing on lab animals with no negative effects after repeated ingestion at levels thousands of times higher than needed to eliminate pathogens. Due to the extremely encouraging results related to efficacy, the Microbiologist-in-Chief of Mount Sinai Hospital who conducted the studies, Dr. Tony Mazzulli, has recommended exploring the use of this compound for the treatment of human infectious disease, which is currently underway. The efficacy testing included several dangerous and hard to deal with antimicrobial resistant strains of bacteria. These results, combined with the excellent safety profile established to date, has resulted in ZEN having discussions with several interested parties from the pharmaceutical industry, organizations focused on antimicrobial resistance and world-class researchers in academia.Greg Fenton, ZEN CEO commented: \"Our focus as a company is developing technology that helps protect people and the environment. An integral part of that is working with experts and independent third parties to validate effectiveness and safety. Through this approach we have proven that our t...